ANDA 91330, held by Am Regent. Trimethobenzamide Hydrochloride.
As of Nov 16, 2026, ANDA 91330 (Trimethobenzamide Hydrochloride), held by Am Regent, was first approved by FDA on Mar 8, 2011, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 8, 2011 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Trimethobenzamide Hydrochloride100MG/ML ยท injectable;injection | Trimethobenzamide Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters